Exact Mass: 335.0518

Exact Mass Matches: 335.0518

Found 29 metabolites which its exact mass value is equals to given mass value 335.0518, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

sulfanitran

sulfanitran

C14H13N3O5S (335.0576)


C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

   

isoxicam

4-hydroxy-2-methyl-N-(5-methyl-2,3-dihydro-1,2-oxazol-3-ylidene)-1,1-dioxo-2H-1λ⁶,2-benzothiazine-3-carboxamide

C14H13N3O5S (335.0576)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

2-Methyl-N-(5-methyl-3-isoxazolyl)-1,1,4-trioxo-3H-1$l^{6},2-benzothiazine-3-carboxamide

2-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,1,4-trioxo-3,4-dihydro-2H-1lambda6,2-benzothiazine-3-carboxamide

C14H13N3O5S (335.0576)


   

isoxicam

isoxicam

C14H13N3O5S (335.0576)


A monocarboxylic acid amide that is piroxicam in which the pyrid-2-yl group is replaced by a 5-methyl-1,2-oxazol-3-yl group. A non-steroidal anti-inflammatory drug, it was withdrawn from the market in the 1980s following its association with cases of Stevens-Johnson syndrome. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

ZINC82843

ZINC82843

C14H13N3O5S (335.0576)


   

CAY10443

(1S)-2,3-dihydro-1H-inden-1-yl ester [(3,4-dichlorophenyl)methyl]-carbamic acid

C17H15Cl2NO2 (335.048)


   

6-(p-Toluidino)-2-naphthalenesulfonic acid sodium salt

6-(p-Toluidino)-2-naphthalenesulfonic acid sodium salt

C17H14NNaO3S (335.0592)


   

6-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID

6-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID

C17H9F4NO2 (335.0569)


   

8-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID

8-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID

C17H9F4NO2 (335.0569)


   

Fluorescent brightener 121

Fluorescent brightener 121

C15H14ClN3O2S (335.0495)


   

(+/-)-N,N-DIMETHYL-1-FERROCENYLETHYLAMINE

(+/-)-N,N-DIMETHYL-1-FERROCENYLETHYLAMINE

C16H18BrNO2 (335.0521)


   

4-AMINO-6-PHENYLPYRIMIDINE

4-AMINO-6-PHENYLPYRIMIDINE

C16H14ClNO5 (335.056)


   

3-carboxy-5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid

3-carboxy-5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid

C16H14ClNO5 (335.056)


   

chlordiazepoxide hydrochloride

chlordiazepoxide hydrochloride

C16H15Cl2N3O (335.0592)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]benzenesulphonamide

4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]benzenesulphonamide

C15H14ClN3O2S (335.0495)


   

methyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

methyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

C16H18BrNO2 (335.0521)


   

5-Formyl-2-deoxy-cytidine-5-monophosphate

5-Formyl-2-deoxy-cytidine-5-monophosphate

C10H14N3O8P (335.0518)


   

5-Hydroxymethyldeoxycytidylate(2-)

5-Hydroxymethyldeoxycytidylate(2-)

C10H14N3O8P-2 (335.0518)


   

Tetracenomycin D

Tetracenomycin D

C19H11O6- (335.0556)


   

2-Methyl-N-(5-methyl-3-isoxazolyl)-1,1,4-trioxo-3H-1$l^{6},2-benzothiazine-3-carboxamide

2-Methyl-N-(5-methyl-3-isoxazolyl)-1,1,4-trioxo-3H-1$l^{6},2-benzothiazine-3-carboxamide

C14H13N3O5S (335.0576)


   

[4-[3,4-Dihydroxy-2-(hydroxymethyl)thiolan-1-ium-1-yl]-1,3-dihydroxybutan-2-yl] hydrogen sulfate

[4-[3,4-Dihydroxy-2-(hydroxymethyl)thiolan-1-ium-1-yl]-1,3-dihydroxybutan-2-yl] hydrogen sulfate

C9H19O9S2+ (335.047)


   

N-(2-chlorophenyl)-2-[[cyclopropyl(oxo)methyl]amino]-4-methyl-5-thiazolecarboxamide

N-(2-chlorophenyl)-2-[[cyclopropyl(oxo)methyl]amino]-4-methyl-5-thiazolecarboxamide

C15H14ClN3O2S (335.0495)


   

[(1S)-2,3-dihydro-1H-inden-1-yl] N-[(3,4-dichlorophenyl)methyl]carbamate

[(1S)-2,3-dihydro-1H-inden-1-yl] N-[(3,4-dichlorophenyl)methyl]carbamate

C17H15Cl2NO2 (335.048)


   

(R)-SKF 38393 hydrobromide

(R)-SKF 38393 hydrobromide

C16H18BrNO2 (335.0521)


   

2-(2,3-dichlorophenoxy)-N-(2,3-dihydro-1H-inden-5-yl)acetamide

2-(2,3-dichlorophenoxy)-N-(2,3-dihydro-1H-inden-5-yl)acetamide

C17H15Cl2NO2 (335.048)


   

1-(3-chloro-4-methylphenyl)-5-oxo-N-(1,3-thiazol-2-yl)pyrrolidine-3-carboxamide

1-(3-chloro-4-methylphenyl)-5-oxo-N-(1,3-thiazol-2-yl)pyrrolidine-3-carboxamide

C15H14ClN3O2S (335.0495)


   

5-methyl-CMP(2-)

5-methyl-CMP(2-)

C10H14N3O8P-2 (335.0518)


   

(S)-SKF 38393 hydrobromide

(S)-SKF 38393 hydrobromide

C16H18BrNO2 (335.0521)


   

[7-[(3-Cyanophenyl)sulfonylamino]-4-methylindol-3-ylidene]methylideneazanide

[7-[(3-Cyanophenyl)sulfonylamino]-4-methylindol-3-ylidene]methylideneazanide

C17H11N4O2S- (335.0603)